Commercial partnership development for RespiHeart in India
Reference number | |
Coordinator | RespiHeart AB |
Funding from Vinnova | SEK 100 000 |
Project duration | October 2024 - March 2025 |
Status | Completed |
Venture | Medtech4Health: Competence Enhancement in SME |
Call | Medtech4Health: Competence Enhancement in Small Businesses 2024 |
Important results from the project
The aim was to initiate discussions with potential partners for product development and commercialization in India. Three sub-goals were achieved during the project: 1. Identification of potential medtech companies, in India 2. Online introductory meetings with prioritized companies 3. Physical meetings with 2-3 companies on site in India The overall goal, to reach a collaboration agreement for product development, remains to be realized. Ongoing follow-up from completed meetings has continued.
Expected long term effects
1. Product development in partnership 2. Commercial development, with a global focus 3. Continued research and development (RespiHeart´s core business) 4. IP development / extension of the RespiHeart method, with more parameters and stronger protection
Approach and implementation
The project was run in collaboration with Business Sweden and their team in India. The main work steps were: - Criteria for target companies - Identification and evaluation - Contacts - Booking and online meetings - Mutual evaluation, in some cases additional online meetings were carried out - Meeting booking and planning for implementation of physical meetings - Implementation of meetings - Ongoing follow-up and next steps The project followed the plan both in terms of time and content.